{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T00:56:17Z","timestamp":1794012977687,"version":"4.8.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:00:00Z","timestamp":1773187200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009827","name":"Alexandria University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009827","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Obesity is a chronic condition characterized by low-grade systemic inflammation, oxidative stress, and impaired fibrinolysis, all of which contribute to elevated cardiovascular risk. This study aimed to investigate the association between carotid intima-media thickness (CIMT), oxidized Low-Density Lipoprotein (ox-LDL), plasminogen activator inhibitor-1 (PAI-1), and inflammatory biomarkers in patients with obesity undergoing sleeve gastrectomy (SG), a widely performed metabolic and bariatric surgery (MBS) procedure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This prospective study included 93 patients with obesity who underwent SG. CIMT, body mass index (BMI), and waist-hip ratio were measured preoperatively and one year postoperatively. Concurrently, serum levels of ox-LDL, PAI-1, lipid profile, HOMA-IR, leptin, and high-sensitivity C-reactive protein (hs-CRP) were assessed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      One year after surgery, significant reductions were observed in CIMT, anthropometric parameters, inflammatory biomarkers (leptin, hs-CRP), insulin resistance, ox-LDL, and PAI-1 levels, along with improvement in lipid profile. PAI-1 was positively correlated with ox-LDL (MD: 5.94, 95% CI: 4.48\u20137.39;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and ox-LDL was a predictor of PAI-1 levels (MD: 0.05, 95% CI: 0.04\u20130.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). In ROC analysis for predicting CIMT\u2009\u2265\u20091\u00a0mm, ox-LDL showed acceptable discriminative ability (AUC: 0.73; sensitivity: 82.1%, specificity: 64.8%), while PAI-1 demonstrated limited performance (AUC: 0.64; sensitivity: 48.7%, specificity: 79.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Weight loss following SG was associated with improvement in inflammatory, oxidative, and fibrinolytic biomarkers. Ox-LDL was more strongly linked to CIMT than PAI-1, which showed limited predictive value. Further studies are needed to evaluate the relationship between CIMT and other fibrinolysis biomarkers such as thrombin-activatable fibrinolysis inhibitor (TAFI) and D-dimer in the context of MBS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11695-026-08538-z","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T02:11:05Z","timestamp":1773195065000},"page":"1414-1426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Carotid Intima\u2013media Thickness is Lower after Sleeve Gastrectomy, with Concurrent Changes in Oxidized LDL and PAI-1"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6650-8112","authenticated-orcid":false,"given":"Mohamed","family":"Hany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0274-9608","authenticated-orcid":false,"given":"Bart","family":"Torensma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy E.","family":"Arida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala M.","family":"Demerdash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shaaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeyad Mohamed","family":"Hany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed N.","family":"Roushdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,11]]},"reference":[{"issue":"4","key":"8538_CR1","doi-asserted-by":"publisher","first-page":"6184","DOI":"10.3390\/ijms15046184","volume":"15","author":"UJ Jung","year":"2014","unstructured":"Jung UJ, Choi M-S. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184\u2013223. https:\/\/doi.org\/10.3390\/ijms15046184.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"8538_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","volume":"13","author":"F Rubino","year":"2025","unstructured":"Rubino F, Cummings DE, Eckel RH, Cohen RV, Wilding JPH, Brown WA, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221\u201362. https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"38","key":"8538_CR3","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1093\/eurheartj\/ehaf314","volume":"46","author":"S Romeo","year":"2025","unstructured":"Romeo S, Vidal-Puig A, Husain M, Ahima R, Arca M, Bhatt DL, et al. Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement. Eur Heart J. 2025;46(38):3685\u2013713. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf314.","journal-title":"Eur Heart J"},{"issue":"8","key":"8538_CR4","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/eurjpc\/zwae025","volume":"31","author":"A Welsh","year":"2024","unstructured":"Welsh A, Hammad M, Pi\u00f1a IL, Kulinski J. Obesity and cardiovascular health. Eur J Prev Cardiol. 2024;31(8):1026\u201335. https:\/\/doi.org\/10.1093\/eurjpc\/zwae025.","journal-title":"Eur J Prev Cardiol"},{"key":"8538_CR5","doi-asserted-by":"publisher","unstructured":"Hany M, Zidan MH, El Shamarka A, Cohen RV,  2025 From body mass index to biology: reconciling diagnostic clarity and surgical eligibility in obesity care. Obes Surg.\u00a0https:\/\/doi.org\/10.1007\/s11695-025-08411-5","DOI":"10.1007\/s11695-025-08411-5"},{"issue":"10382","key":"8538_CR6","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/s0140-6736(22)02403-5","volume":"401","author":"CM Perdomo","year":"2023","unstructured":"Perdomo CM, Cohen RV, Sumithran P, Cl\u00e9ment K, Fr\u00fchbeck G. Contemporary medical, device, and surgical therapies for obesity in adults. Lancet. 2023;401(10382):1116\u201330. https:\/\/doi.org\/10.1016\/s0140-6736(22)02403-5.","journal-title":"Lancet"},{"issue":"5","key":"8538_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052721","volume":"22","author":"M Sillen","year":"2021","unstructured":"Sillen M, Declerck PJ. A narrative review on plasminogen activator inhibitor-1 and its (patho)physiological role: to target or not to target? Int J Mol Sci. 2021;22(5):2721. https:\/\/doi.org\/10.3390\/ijms22052721.","journal-title":"Int J Mol Sci"},{"key":"8538_CR8","doi-asserted-by":"crossref","unstructured":"Kaji H, 2016 Adipose Tissue-Derived Plasminogen Activator Inhibitor\u20101 Function and Regulation. In: Comprehensive Physiology. Wiley p. 1873\u201396.","DOI":"10.1002\/cphy.c160004"},{"key":"8538_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.622473","volume":"7","author":"M Sillen","year":"2020","unstructured":"Sillen M, Declerck PJ. Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition. Front Cardiovasc Med. 2020;7:622473. https:\/\/doi.org\/10.3389\/fcvm.2020.622473.","journal-title":"Front Cardiovasc Med"},{"key":"8538_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12959-018-0166-4","volume":"16","author":"RG Jung","year":"2018","unstructured":"Jung RG, Motazedian P, Ramirez FD, Simard T, Di Santo P, Visintini S, et al. Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis. Thromb J. 2018;16:12\u201312. https:\/\/doi.org\/10.1186\/s12959-018-0166-4.","journal-title":"Thromb J"},{"issue":"2","key":"8538_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.coph.2005.01.007","volume":"5","author":"BD Taeye","year":"2005","unstructured":"Taeye BD, Smith LH, Vaughan DE. Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease. Curr Opin Pharmacol. 2005;5(2):149\u201354. https:\/\/doi.org\/10.1016\/j.coph.2005.01.007.","journal-title":"Curr Opin Pharmacol"},{"key":"8538_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.thromres.2016.02.002","volume":"140","author":"GH Tofler","year":"2016","unstructured":"Tofler GH, Massaro J, O\u2019Donnell CJ, Wilson PWF, Vasan RS, Sutherland PA, Meigs JB, Levy D. D\u2019Agostino RB, Sr. Plasminogen activator inhibitor and the risk of cardiovascular disease: the Framingham heart study. Thromb Res. 2016;140:30\u20135. https:\/\/doi.org\/10.1016\/j.thromres.2016.02.002.","journal-title":"Thromb Res"},{"issue":"10","key":"8538_CR13","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1161\/01.atv.0000242905.41404.68","volume":"26","author":"M-C Alessi","year":"2006","unstructured":"Alessi M-C, Juhan-Vague I. PAI-1 and the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2006;26(10):2200\u20137. https:\/\/doi.org\/10.1161\/01.atv.0000242905.41404.68.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"8538_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s001250050868","volume":"41","author":"P Eriksson","year":"1998","unstructured":"Eriksson P, Reynisdottir S, L\u00f6nnqvist F, Stemme V, Hamsten A, Arner P. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals. Diabetologia. 1998;41(1):65\u201371. https:\/\/doi.org\/10.1007\/s001250050868.","journal-title":"Diabetologia"},{"issue":"6","key":"8538_CR15","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.blre.2016.05.002","volume":"30","author":"SA Barnard","year":"2016","unstructured":"Barnard SA, Pieters M, De Lange Z. The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels. Blood Rev. 2016;30(6):421\u20139. https:\/\/doi.org\/10.1016\/j.blre.2016.05.002.","journal-title":"Blood Rev"},{"issue":"12","key":"8538_CR16","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/j.cjca.2017.07.015","volume":"33","author":"S Gao","year":"2017","unstructured":"Gao S, Zhao D, Wang M, Zhao F, Han X, Qi Y, et al. Association between circulating oxidized LDL and atherosclerotic cardiovascular disease: a meta-analysis of observational studies. Can J Cardiol. 2017;33(12):1624\u201332. https:\/\/doi.org\/10.1016\/j.cjca.2017.07.015.","journal-title":"Can J Cardiol"},{"issue":"1","key":"8538_CR17","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41598-020-79948-x","volume":"11","author":"JA Levine","year":"2021","unstructured":"Levine JA, Oleaga C, Eren M, Amaral AP, Shang M, Lux E, Khan SS, Shah SJ, Omura Y, Pamir N, et al. Role of PAI-1 in hepatic steatosis and dyslipidemia. Sci Rep. 2021;11(1):430\u2013430. https:\/\/doi.org\/10.1038\/s41598-020-79948-x.","journal-title":"Sci Rep"},{"issue":"7","key":"8538_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071018","volume":"10","author":"D Kanikowska","year":"2021","unstructured":"Kanikowska D, Kanikowska A, Swora-Cwynar E, Grzymis\u0142awski M, Sato M, Br\u0119borowicz A, et al. Moderate caloric restriction partially improved oxidative stress markers in obese humans. Antioxidants. 2021;10(7):1018. https:\/\/doi.org\/10.3390\/antiox10071018.","journal-title":"Antioxidants"},{"issue":"2","key":"8538_CR19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.tem.2016.11.002","volume":"28","author":"YI Miller","year":"2017","unstructured":"Miller YI, Shyy JYJ. Context-dependent role of oxidized lipids and lipoproteins in inflammation. Trends Endocrinol Metab. 2017;28(2):143\u201352. https:\/\/doi.org\/10.1016\/j.tem.2016.11.002.","journal-title":"Trends Endocrinol Metab"},{"issue":"23suppl1","key":"8538_CR20","doi-asserted-by":"publisher","first-page":"III","DOI":"10.1161\/01.CIR.0000131512.50667.46","volume":"109","author":"G Assmann","year":"2004","unstructured":"Assmann G, Gotto AM. HDL cholesterol and protective factors in atherosclerosis. Circulation. 2004;109(23suppl1):III\u20138. https:\/\/doi.org\/10.1161\/01.CIR.0000131512.50667.46.","journal-title":"Circulation"},{"key":"8538_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9596054","volume":"2018","author":"S Somodi","year":"2018","unstructured":"Somodi S, Seres I, L\u0151rincz H, Harangi M, F\u00fcl\u00f6p P, Paragh G. Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese nondiabetic subjects. Int J Endocrinol. 2018;2018:9596054. https:\/\/doi.org\/10.1155\/2018\/9596054.","journal-title":"Int J Endocrinol"},{"issue":"6","key":"8538_CR22","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1161\/01.ATV.20.6.1688","volume":"20","author":"S Ren","year":"2000","unstructured":"Ren S, Shen GX. Impact of antioxidants and HDL on glycated LDL\u2013induced generation of fibrinolytic regulators from vascular endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20(6):1688\u201393. https:\/\/doi.org\/10.1161\/01.ATV.20.6.1688.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"8538_CR23","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000622","volume":"67","author":"M Can","year":"2023","unstructured":"Can M, Kocabas M, Yarar Z, Burgucu H, Karak\u00f6se M, Yerlikaya FH, et al. Evaluation of subclinical atherosclerosis in obese patients with three noninvasive methods: arterial stiffness, carotid intima-media thickness, and biomarkers of endothelial dysfunction. Arch Endocrinol Metab. 2023;67(4):e000622. https:\/\/doi.org\/10.20945\/2359-3997000000622.","journal-title":"Arch Endocrinol Metab"},{"issue":"5","key":"8538_CR24","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1007\/s11695-022-05976-3","volume":"32","author":"N Nabavi","year":"2022","unstructured":"Nabavi N, Ghodsi A, Rostami R, Torshizian A, Jamialahmadi T, Jangjoo A, et al. Impact of bariatric surgery on carotid intima-media thickness in patients with morbid obesity: a prospective study and review of the literature. Obes Surg. 2022;32(5):1563\u20139. https:\/\/doi.org\/10.1007\/s11695-022-05976-3.","journal-title":"Obes Surg"},{"issue":"6","key":"8538_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11060505","volume":"11","author":"AM Rychter","year":"2021","unstructured":"Rychter AM, Naskr\u0119t D, Zawada A, Ratajczak AE, Dobrowolska A, Krela-Ka\u017amierczak I. What can we change in diet and behaviour in order to decrease carotid intima-media thickness in patients with obesity? J Pers Med. 2021;11(6):505. https:\/\/doi.org\/10.3390\/jpm11060505.","journal-title":"J Pers Med"},{"issue":"10","key":"8538_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.jcmg.2013.11.014","volume":"7","author":"TZ Naqvi","year":"2014","unstructured":"Naqvi TZ, Lee M-S. Carotid intima-media thickness and plaque in cardiovascular risk assessment. JACC: Cardiovasc Imaging. 2014;7(10):1025\u201338. https:\/\/doi.org\/10.1016\/j.jcmg.2013.11.014.","journal-title":"JACC: Cardiovasc Imaging"},{"issue":"1","key":"8538_CR27","doi-asserted-by":"publisher","first-page":"18","DOI":"10.5551\/jat.31989","volume":"23","author":"T Nezu","year":"2016","unstructured":"Nezu T, Hosomi N, Aoki S, Matsumoto M. Carotid intima-media thickness for atherosclerosis. J Atheroscler Thromb. 2016;23(1):18\u201331. https:\/\/doi.org\/10.5551\/jat.31989.","journal-title":"J Atheroscler Thromb"},{"issue":"8","key":"8538_CR28","first-page":"439","volume":"29","author":"SS Bassuk","year":"2004","unstructured":"Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol. 2004;29(8):439\u201393.","journal-title":"Curr Probl Cardiol"},{"issue":"1","key":"8538_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-025-01930-3","volume":"25","author":"JA Mohammed","year":"2025","unstructured":"Mohammed JA, Basil B, Mba IN, Abubakar ND, Lawal AO, Momoh JA, et al. Elevated high-sensitivity C-reactive protein and dyslipidaemia in type 2 diabetes mellitus: implications for cardiovascular risk prediction in Nigerian patients. BMC Endocr Disord. 2025;25(1):100. https:\/\/doi.org\/10.1186\/s12902-025-01930-3.","journal-title":"BMC Endocr Disord"},{"issue":"2","key":"8538_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/1753-0407.12970","volume":"12","author":"JK Beverly","year":"2020","unstructured":"Beverly JK, Budoff MJ. Atherosclerosis: pathophysiology of insulin resistance, hyperglycemia, hyperlipidemia, and inflammation. J Diabetes. 2020;12(2):102\u20134. https:\/\/doi.org\/10.1111\/1753-0407.12970.","journal-title":"J Diabetes"},{"issue":"22","key":"8538_CR31","doi-asserted-by":"publisher","first-page":"3887","DOI":"10.3889\/oamjms.2019.526","volume":"7","author":"DA Swastini","year":"2019","unstructured":"Swastini DA, Wiryanthini IAD, Ariastuti NLP, Muliantara A. Atherosclerosis prediction with high sensitivity C-reactive protein (hs-CRP) and related risk factor in patient with dyslipidemia. Open Access Maced J Med Sci. 2019;7(22):3887\u201390. https:\/\/doi.org\/10.3889\/oamjms.2019.526.","journal-title":"Open Access Maced J Med Sci"},{"issue":"9","key":"8538_CR32","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s11695-024-07441-9","volume":"34","author":"M Hany","year":"2024","unstructured":"Hany M, Demerdash HM, Abouelnasr AA, Agayby ASS, Ibrahim M, Arida RE, et al. Relationship between weight loss, changes in serum hs-CRP levels and Apo A-1 lipoprotein, and high-density lipoprotein-cholesterol ratios as predictors for improved cardiovascular risk factors after laparoscopic sleeve gastrectomy. Obes Surg. 2024;34(9):3401\u201311. https:\/\/doi.org\/10.1007\/s11695-024-07441-9.","journal-title":"Obes Surg"},{"issue":"5","key":"8538_CR33","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1007\/s11695-024-07196-3","volume":"34","author":"WA Brown","year":"2024","unstructured":"Brown WA, Liem R, Al-Sabah S, Anvari M, Boza C, Cohen RV, et al. Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report. Obes Surg. 2024;34(5):1764\u201377. https:\/\/doi.org\/10.1007\/s11695-024-07196-3.","journal-title":"Obes Surg"},{"issue":"4","key":"8538_CR34","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","volume":"34","author":"L Angrisani","year":"2024","unstructured":"Angrisani L, Santonicola A, Iovino P, Palma R, Kow L, Prager G, et al. IFSO worldwide survey 2020\u20132021: current trends for bariatric and metabolic procedures. Obes Surg. 2024;34(4):1075\u201385. https:\/\/doi.org\/10.1007\/s11695-024-07118-3.","journal-title":"Obes Surg"},{"key":"8538_CR35","doi-asserted-by":"publisher","DOI":"10.1007\/s11695-025-07846-0","author":"MH Zidan","year":"2025","unstructured":"Zidan MH, Abokhozima A, Gaber MIA, Amgad A, Altabbaa H, El-Masry H, et al. Trends and practices in bariatric surgery in Egypt: insights on esophagogastroduodenoscopy (EGD) utilization and surgical volumes. Obes Surg. 2025. https:\/\/doi.org\/10.1007\/s11695-025-07846-0.","journal-title":"Obes Surg"},{"issue":"6","key":"8538_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8060168","volume":"8","author":"A Metere","year":"2020","unstructured":"Metere A, Graves CE, Pietraforte D, Casella G. The effect of sleeve gastrectomy on oxidative stress in obesity. Biomedicines. 2020;8(6):168.","journal-title":"Biomedicines"},{"key":"8538_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.metabol.2019.07.002","volume":"99","author":"N Cabr\u00e9","year":"2019","unstructured":"Cabr\u00e9 N, Luciano-Mateo F, Fern\u00e1ndez-Arroyo S, Baiges-Gay\u00e0 G, Hern\u00e1ndez-Aguilera A, Fibla M, et al. Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation. Metabolism. 2019;99:81\u20139.","journal-title":"Metabolism"},{"issue":"6","key":"8538_CR38","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1007\/s11695-024-07244-y","volume":"34","author":"MM Rossi","year":"2024","unstructured":"Rossi MM, Signorini FJ, Castillo TA, Parada MPS, Moser F, Baez M. Sleeve gastrectomy reduces oxidative stress and reverses mitochondrial dysfunction associated with metabolic syndrome. Obes Surg. 2024;34(6):2042\u201353.","journal-title":"Obes Surg"},{"issue":"1","key":"8538_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","volume":"33","author":"D Eisenberg","year":"2023","unstructured":"Eisenberg D, Shikora SA, Aarts E, Aminian A, Angrisani L, Cohen RV, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33(1):3\u201314. https:\/\/doi.org\/10.1007\/s11695-022-06332-1.","journal-title":"Obes Surg"},{"key":"8538_CR40","first-page":"8","volume":"2008","author":"W Consultation","year":"2008","unstructured":"Consultation W. Waist circumference and waist-hip ratio. Report of a WHO expert consultation Geneva. World Health Organ. 2008;2008:8\u201311.","journal-title":"World Health Organ"},{"issue":"9","key":"8538_CR41","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","volume":"30","author":"L Busetto","year":"2024","unstructured":"Busetto L, Dicker D, Fr\u00fchbeck G, Halford JCG, Sbraccia P, Yumuk V, Goossens GH. A new framework for the diagnosis, staging and management of obesity in adults. Nat Med. 2024;30(9):2395\u20139. https:\/\/doi.org\/10.1038\/s41591-024-03095-3.","journal-title":"Nat Med"},{"issue":"6","key":"8538_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499\u2013502.","journal-title":"Clin Chem"},{"key":"8538_CR43","doi-asserted-by":"publisher","unstructured":"Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, Foster E, Hlatky MA, Hodgson JM, Kushner FG, et al. 2010 ACCF\/AHA guideline for assessment of cardiovascular risk in asymptomatic adults. Circulation. 122(25). https:\/\/doi.org\/10.1161\/cir.0b013e3182051b4c.","DOI":"10.1161\/cir.0b013e3182051b4c"},{"issue":"3","key":"8538_CR44","doi-asserted-by":"publisher","first-page":"427","DOI":"10.2174\/1570161112666140423221319","volume":"12","author":"A Briones","year":"2014","unstructured":"Briones A, Aras-Lopez R, Alonso M, Salaices M. Small artery remodeling in obesity and insulin resistance. Curr Vasc Pharmacol. 2014;12(3):427\u201337. https:\/\/doi.org\/10.2174\/1570161112666140423221319.","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"8538_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10030406","volume":"10","author":"E Mart\u00ednez-Mart\u00ednez","year":"2021","unstructured":"Mart\u00ednez-Mart\u00ednez E, Souza-Neto F, Jim\u00e9nez-Gonz\u00e1lez S, Cachofeiro V. Oxidative stress and vascular damage in the context of obesity: the hidden guest. Antioxidants. 2021;10(3):406. https:\/\/doi.org\/10.3390\/antiox10030406.","journal-title":"Antioxidants"},{"issue":"6","key":"8538_CR46","doi-asserted-by":"publisher","first-page":"929","DOI":"10.33549\/physiolres.935384","volume":"73","author":"B Muffov\u00e1","year":"2024","unstructured":"Muffov\u00e1 B, Kr\u00e1lov\u00e1 Lesn\u00e1 I, Poledne R. Physiology and pathobiology of perivascular adipose tissue: inflammation-based atherogenesis. Physiol Res. 2024;73(6):929\u201341. https:\/\/doi.org\/10.33549\/physiolres.935384.","journal-title":"Physiol Res"},{"key":"8538_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal2658","author":"AS Antonopoulos","year":"2017","unstructured":"Antonopoulos AS, Sanna F, Sabharwal N, Thomas S, Oikonomou EK, Herdman L, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017. https:\/\/doi.org\/10.1126\/scitranslmed.aal2658.","journal-title":"Sci Transl Med"},{"key":"8538_CR48","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejphar.2015.09.012","volume":"766","author":"G Ozen","year":"2015","unstructured":"Ozen G, Daci A, Norel X, Topal G. Human perivascular adipose tissue dysfunction as a cause of vascular disease: focus on vascular tone and wall remodeling. Eur J Pharmacol. 2015;766:16\u201324. https:\/\/doi.org\/10.1016\/j.ejphar.2015.09.012.","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"8538_CR49","doi-asserted-by":"publisher","first-page":"860","DOI":"10.2337\/diabetes.46.5.860","volume":"46","author":"MC Alessi","year":"1997","unstructured":"Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I. Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 1997;46(5):860\u20137. https:\/\/doi.org\/10.2337\/diabetes.46.5.860.","journal-title":"Diabetes"},{"issue":"3","key":"8538_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.2174\/1568016043356255","volume":"2","author":"G Fr\u00fchbeck","year":"2004","unstructured":"Fr\u00fchbeck G. The adipose tissue as a source of vasoactive factors. Current medicinal chemistry Cardiovascular and hematological agents. 2004;2(3):197\u2013208. https:\/\/doi.org\/10.2174\/1568016043356255.","journal-title":"Current medicinal chemistry Cardiovascular and hematological agents"},{"issue":"1","key":"8538_CR51","doi-asserted-by":"publisher","first-page":"200","DOI":"10.2337\/db09-0700","volume":"59","author":"JM Moreno-Navarrete","year":"2010","unstructured":"Moreno-Navarrete JM, Mart\u00ednez-Barricarte R, Catal\u00e1n V, Sabater M, G\u00f3mez-Ambrosi J, Ortega FJ, et al. Complement factor H is expressed in adipose tissue in association with insulin resistance. Diabetes. 2010;59(1):200\u20139. https:\/\/doi.org\/10.2337\/db09-0700.","journal-title":"Diabetes"},{"issue":"3","key":"8538_CR52","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1381\/096089206776116525","volume":"16","author":"J G\u00f3mez-Ambrosi","year":"2006","unstructured":"G\u00f3mez-Ambrosi J, Salvador J, Rotellar F, Silva C, Catal\u00e1n V, Rodr\u00edguez A, et al. Increased serum amyloid A concentrations in morbid obesity decrease after gastric bypass. Obes Surg. 2006;16(3):262\u20139. https:\/\/doi.org\/10.1381\/096089206776116525.","journal-title":"Obes Surg"},{"issue":"7067","key":"8538_CR53","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/438436b","volume":"438","author":"G Fr\u00fchbeck","year":"2005","unstructured":"Fr\u00fchbeck G. Aquaporin enters the picture. Nature. 2005;438(7067):436\u20137. https:\/\/doi.org\/10.1038\/438436b.","journal-title":"Nature"},{"key":"8538_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120424","volume":"408","author":"DB Matar","year":"2025","unstructured":"Matar DB, Elahi MA, Sukkarieh H, Nassar WK, Aljada A. Unlocking the secrets: adipose tissue dysfunction and atherosclerosis-mechanisms and innovative therapeutic approaches. Atherosclerosis. 2025;408:120424. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.120424.","journal-title":"Atherosclerosis"},{"issue":"15","key":"8538_CR55","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.cir.0000161823.55935.be","volume":"111","author":"G Rega","year":"2005","unstructured":"Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, et al. Inflammatory cytokines interleukin-6 and oncostatin M induce plasminogen activator inhibitor-1 in human adipose tissue. Circulation. 2005;111(15):1938\u201345. https:\/\/doi.org\/10.1161\/01.cir.0000161823.55935.be.","journal-title":"Circulation"},{"key":"8538_CR56","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063170","author":"R Altalhi","year":"2021","unstructured":"Altalhi R, Pechlivani N, Ajjan RA. PAI-1 in diabetes: pathophysiology and role as a therapeutic target. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22063170.","journal-title":"Int J Mol Sci"},{"key":"8538_CR57","doi-asserted-by":"publisher","first-page":"9596054","DOI":"10.1155\/2018\/9596054","volume":"2018","author":"S Somodi","year":"2018","unstructured":"Somodi S, Seres I, L\u0151rincz H, Harangi M, F\u00fcl\u00f6p P, Paragh G. Plasminogen activator inhibitor-1 level correlates with lipoprotein subfractions in obese nondiabetic subjects. Int J Endocrinol. 2018;2018:9596054\u20139596054. https:\/\/doi.org\/10.1155\/2018\/9596054.","journal-title":"Int J Endocrinol"},{"issue":"15","key":"8538_CR58","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.15.1678","volume":"168","author":"S Eichinger","year":"2008","unstructured":"Eichinger S. Overweight, obesity, and the risk of recurrent venous thromboembolism. Arch Intern Med. 2008;168(15):1678. https:\/\/doi.org\/10.1001\/archinte.168.15.1678.","journal-title":"Arch Intern Med"},{"issue":"5","key":"8538_CR59","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","volume":"28","author":"M Cesari","year":"2010","unstructured":"Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther. 2010;28(5):e72\u201391. https:\/\/doi.org\/10.1111\/j.1755-5922.2010.00171.x.","journal-title":"Cardiovasc Ther"},{"issue":"6","key":"8538_CR60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2217\/17460875.3.6.637","volume":"3","author":"P Holvoet","year":"2008","unstructured":"Holvoet P, De Keyzer D, Jacobs DR Jr. Oxidized LDL and the metabolic syndrome. Future Lipidol. 2008;3(6):637\u201349. https:\/\/doi.org\/10.2217\/17460875.3.6.637.","journal-title":"Future Lipidol"},{"issue":"3","key":"8538_CR61","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/ncpcardio0500","volume":"3","author":"A Kontush","year":"2006","unstructured":"Kontush A, Chapman MJ. Antiatherogenic small, dense HDL\u2014guardian angel of the arterial wall? Nat Clin Pract Cardiovasc Med. 2006;3(3):144\u201353. https:\/\/doi.org\/10.1038\/ncpcardio0500.","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"3","key":"8538_CR62","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/jth.13925","volume":"16","author":"G Obermayer","year":"2018","unstructured":"Obermayer G, Afonyushkin T, Binder CJ. Oxidized low-density lipoprotein in inflammation\u2010driven thrombosis. J Thromb Haemost. 2018;16(3):418\u201328. https:\/\/doi.org\/10.1111\/jth.13925.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"8538_CR63","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2337\/db16-0933","volume":"66","author":"Y Hurtado-Roca","year":"2016","unstructured":"Hurtado-Roca Y, Bueno H, Fernandez-Ortiz A, Ordovas JM, Iba\u00f1ez B, Fuster V, et al. Oxidized LDL is associated with metabolic syndrome traits independently of central obesity and insulin resistance. Diabetes. 2016;66(2):474\u201382. https:\/\/doi.org\/10.2337\/db16-0933.","journal-title":"Diabetes"},{"issue":"3","key":"8538_CR64","doi-asserted-by":"publisher","first-page":"e0143102","DOI":"10.1371\/journal.pone.0143102","volume":"11","author":"ME Harmon","year":"2016","unstructured":"Harmon ME, Campen MJ, Miller C, Shuey C, Cajero M, Lucas S, et al. Associations of circulating oxidized LDL and conventional biomarkers of cardiovascular disease in a cross-sectional study of the Navajo population. PLoS One. 2016;11(3):e0143102\u2013e0143102. https:\/\/doi.org\/10.1371\/journal.pone.0143102.","journal-title":"PLoS One"},{"key":"8538_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110040","volume":"191","author":"L Xu","year":"2022","unstructured":"Xu L, Yan X, Tang Z, Feng B. Association between circulating oxidized OxLDL\/LDL-C ratio and the severity of coronary atherosclerosis, along with other emerging biomarkers of cardiovascular disease in patients with type 2 diabetes. Diabetes Res Clin Pract. 2022;191:110040. https:\/\/doi.org\/10.1016\/j.diabres.2022.110040.","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"8538_CR66","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1007\/s11695-019-03926-0","volume":"29","author":"M Askarpour","year":"2019","unstructured":"Askarpour M, Khani D, Sheikhi A, Ghaedi E, Alizadeh S. Effect of bariatric surgery on serum inflammatory factors of obese patients: a systematic review and meta-analysis. Obes Surg. 2019;29(8):2631\u201347. https:\/\/doi.org\/10.1007\/s11695-019-03926-0.","journal-title":"Obes Surg"},{"key":"8538_CR67","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.2147\/DMSO.S458233","volume":"17","author":"C Sharma","year":"2024","unstructured":"Sharma C, Suliman A, Al Hamad SM, Yasin J, Abuzakouk M, AlKaabi J, et al. Association of biomarkers for dyslipidemia, inflammation, and oxidative stress with endothelial dysfunction in obese youths: a case-control study. Diabetes Metab Syndr Obes. 2024;17:2533\u201345. https:\/\/doi.org\/10.2147\/DMSO.S458233.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"4","key":"8538_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0009-9120(02)00320-x","volume":"35","author":"J G\u00f3mez-Ambrosi","year":"2002","unstructured":"G\u00f3mez-Ambrosi J, Salvador J, P\u00e1ramo JA, Orbe J, de Irala J, Diez-Caballero A, et al. Involvement of leptin in the association between percentage of body fat and cardiovascular risk factors. Clin Biochem. 2002;35(4):315\u201320. https:\/\/doi.org\/10.1016\/s0009-9120(02)00320-x.","journal-title":"Clin Biochem"},{"issue":"3","key":"8538_CR69","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.bbalip.2010.11.011","volume":"1811","author":"A Kuniyasu","year":"2011","unstructured":"Kuniyasu A, Tokunaga M, Yamamoto T, Inoue S, Obama K, Kawahara K, et al. Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression through reactive oxygen species generation and ERK1\/2 activation in 3T3-L1 adipocytes. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 2011;1811(3):153\u201362. https:\/\/doi.org\/10.1016\/j.bbalip.2010.11.011.","journal-title":"Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids"},{"issue":"1","key":"8538_CR70","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2012.06.062","volume":"224","author":"JRH Raiko","year":"2012","unstructured":"Raiko JRH, Oikonen M, Wendelin-Saarenhovi M, Siitonen N, K\u00e4h\u00f6nen M, Lehtim\u00e4ki T, et al. Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2012;224(1):208\u201312. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.06.062.","journal-title":"Atherosclerosis"},{"key":"8538_CR71","doi-asserted-by":"publisher","unstructured":"Singh RP, Chauhan K, Tripathi A, Choudhary R,\u00a02024 Association of adipokines and CIMT in metabolic syndrome in Western Uttar Pradesh population: a Cross-Sectional study. Maedica - J Clin Med 19(4) https:\/\/doi.org\/10.26574\/maedica.2024.19.4.877","DOI":"10.26574\/maedica.2024.19.4.877"},{"issue":"1","key":"8538_CR72","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41598-025-89220-9","volume":"15","author":"Z Dogan","year":"2025","unstructured":"Dogan Z, Senyigit A, Durmus S, Duvarc\u0131 C, Geli\u015fgen R, Uzun H, et al. The relationship between oxLDL, sLOX-1, PCSK9 and carotid intima-media thickness in patients with prediabetes and type 2 diabetes. Sci Rep. 2025;15(1):4554\u20134554. https:\/\/doi.org\/10.1038\/s41598-025-89220-9.","journal-title":"Sci Rep"},{"issue":"5","key":"8538_CR73","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.surg.2023.07.002","volume":"174","author":"CR Machado","year":"2023","unstructured":"Machado CR, Braun AM, Ceolin J, Richter SA, Ribeiro MC, Santos LD, et al. Variation of modulation and expression of biomarkers associated with inflammation in bariatric surgery patients: a systematic review and meta-analysis. Surgery. 2023;174(5):1114\u201344. https:\/\/doi.org\/10.1016\/j.surg.2023.07.002.","journal-title":"Surgery"},{"key":"8538_CR74","doi-asserted-by":"publisher","unstructured":"Babakr AT, 2025 Oxidized low-density lipoproteins and their contribution to atherosclerosis. Explor Cardiol https:\/\/doi.org\/10.37349\/ec.2025.101246","DOI":"10.37349\/ec.2025.101246"},{"issue":"3","key":"8538_CR75","doi-asserted-by":"publisher","first-page":"102394","DOI":"10.1016\/j.rpth.2024.102394","volume":"8","author":"M Rodriguez","year":"2024","unstructured":"Rodriguez M, Zheng Z. Connecting impaired fibrinolysis and dyslipidemia. Res Pract Thromb Haemost. 2024;8(3):102394\u2013102394. https:\/\/doi.org\/10.1016\/j.rpth.2024.102394.","journal-title":"Res Pract Thromb Haemost"},{"key":"8538_CR76","doi-asserted-by":"crossref","unstructured":"Rubenstein DA, Yin W, 2018 Platelet-Activation Mechanisms and Vascular Remodeling. In: Comprehensive Physiology. Wiley p. 1117\u201356.","DOI":"10.1002\/cphy.c170049"},{"key":"8538_CR77","doi-asserted-by":"publisher","first-page":"707529","DOI":"10.3389\/fcvm.2021.707529","volume":"8","author":"K Malekmohammad","year":"2021","unstructured":"Malekmohammad K, Bezsonov EE, Rafieian-Kopaei M. Role of lipid accumulation and inflammation in atherosclerosis: focus on molecular and cellular mechanisms. Front Cardiovasc Med. 2021;8:707529\u2013707529. https:\/\/doi.org\/10.3389\/fcvm.2021.707529.","journal-title":"Front Cardiovasc Med"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08538-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11695-026-08538-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-026-08538-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:17:21Z","timestamp":1776259041000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11695-026-08538-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,11]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["8538"],"URL":"https:\/\/doi.org\/10.1007\/s11695-026-08538-z","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,11]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Medical Research Institute, Alexandria University, Egypt. All procedures were conducted in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments. Written informed consent was obtained from all participants before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}